Developed in response to the COVID-19 pandemic, the Rapidly Emerging Antiviral Drug Development Initiatives AViDD Center (READDI-AC) platform integrates cutting-edge discovery-based academic science with product development-oriented industrial drug development transforming the historically reactive landscape of emerging virus drug development to one that is proactive. READDI-AC components are completed in part by the creation of a FAIR-compatible data analysis platform built on HeLx, alongside Dug as a semantic search and data discovery tool.

Project Team

  • Ashok Krishnamurthy (Technical Lead, Data Management Team)
  • Alex Tropsha (Data Science lead, Data Management Team)


  • UNC Gillings School of Global Public Health
  • VUMC
  • UW Madison
  • NC TraCS
  • Janssen Pharmaceuticals NV (JPNV)
  • Takeda
  • Chimerix
  • Pardes Biosciences